Abstract
This overview presents the pharmacological effectiveness of copper complexes as anticancer and anti-inflammatory agents as a physiological approach to treating cancers and autoimmune diseases [see References 1–8 and references cited therein]. Plasma copper concentration increases in neoplastic and autoimmune diseases as an immune-mediated physiological response to these disease states. Treatment with copper complexes is a therapeutic support of this increase in plasma copper and the attendant distribution of copper to affected tissues to enable de-novo syntheis of copper-dependent enzymes required to bring about remission by re-establishing normal tissue function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sorenson JRJ, ed. Inflammatory Diseases and Copper. Totowa, NJ: Humana Press; 1982.
Sorenson JRJ, ed. Biology of Copper Complexes. Totowa, NJ: Humana Press; 1987.
Sorenson JRJ. An evaluation of altered essential metal concentrations in rheumatoid arthritis. Inorg Perspec Biol Med. 1978;2:1–26.
Sorenson JRJ. Copper complexes in the treatment of experimental inflammatory conditions: inflammation, ulcers, and pain. In: Rainsford KD, Velo GP, eds. Copper and Zinc in Inflammation, Volume IV. Lancaster, UK: MTP Press; 1989: 69–84.
Sorenson JRJ. Copper complexes offer a physiologic approach to treatment of chronic diseases. Prog Med Chem. 1989;26:437–568.
Sorenson JRJ. Copper-potentiation of nonsteroidal antiinflammatory drugs. In: Berthon G, ed. Handbook of Metal-Ligand Interactions in Biological Fluids: Bioinorganic Medicine, Volume 2. New York: Marcel Dekker; 1995: 1318–1324.
Sorenson JRJ. Pharmacological activities of copper compounds. In: Berthon G, ed. Handbook of Metal-Ligand Interactions in Biological Fluids: Bioinorganic Medicine, Volume 2. New York: Marcel Dekker; 1995: 1128–1139.
Baquial JGL, Sorenson JRJ. Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2(3,5-diisopropylsalicylate)4. J Inorg Biochem. 1995;60:133–148.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sorenson, J.R.J. (1998). Copper complexes for therapy of cancer and autoimmune diseases. In: Rainsford, K.D., Milanino, R., Sorenson, J.R.J., Velo, G.P. (eds) Copper and Zinc in Inflammatory and Degenerative Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3963-2_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-3963-2_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5757-8
Online ISBN: 978-94-011-3963-2
eBook Packages: Springer Book Archive